OS13.7.A GENOMIC PROFILING OF 1,104 CONSECUTIVE, PROSPECTIVE MENINGIOMAS DEFINES THE POPULATION PREVALENCE OF MOLECULAR ALTERATIONS AND ELUCIDATES POTENTIAL BIOMARKERS OF TREATMENT RESPONSE. Read more about OS13.7.A GENOMIC PROFILING OF 1,104 CONSECUTIVE, PROSPECTIVE MENINGIOMAS DEFINES THE POPULATION PREVALENCE OF MOLECULAR ALTERATIONS AND ELUCIDATES POTENTIAL BIOMARKERS OF TREATMENT RESPONSE.
Salvage therapies for first relapse of SHH medulloblastoma in early childhood. Read more about Salvage therapies for first relapse of SHH medulloblastoma in early childhood.
Celebrating 30 years of the Society for NeuroOncology and its tremendous impact on the Journal. Read more about Celebrating 30 years of the Society for NeuroOncology and its tremendous impact on the Journal.
Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Read more about Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium. Read more about Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Read more about Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
Point/counterpoint: The role of re-resection in recurrent glioblastoma. Read more about Point/counterpoint: The role of re-resection in recurrent glioblastoma.
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective. Read more about The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Read more about Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Genomic features underlying meningioma sex-specificity. Read more about Genomic features underlying meningioma sex-specificity.
